Skip to content

Moderna MRNA Total costs & expenses

Total costs & expenses at other companies

ALN
Alnylam PharmaceuticalsALNY
Biogen logo
BiogenBIIB
Gilead Sciences logo
Gilead SciencesGILD
Insmed logo
InsmedINSM
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue$389.0M+260%
Gross profit-$566.0M-3,244%
Operating income-$1.4B-32.2%
Net income-$1.3B-38.3%
EPS (diluted)-$3.40-34.9%

Balance sheet

See full
Cash & equivalents$1.9B+17.4%
Total debt$1.3B+71.9%
Total equity$7.4B-26.4%
Total assets$11.5B-9.6%

Cash flow

See full
Operating cash flow-$630.0M+39.3%
CapEx$62.0M-47.0%
Free cash flow-$692.0M+40.0%

Valuation

See full
Market cap$24.52B+83.8%
Enterprise value$23.94B+93.6%
P/S11×+6.8×

Profitability

See full
Gross margin22.1%-32.0pp
Operating margin-153.3%+67.8pp
Net margin-143.6%+80.2pp

Returns & leverage

See full
Return on equity-36.6%+11.9pp
Debt / equity0.2×+0.1×
Current ratio2.4×-1.8×

Where this comes from

Reported directly by Moderna in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Moderna's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Moderna's total costs & expenses?
Moderna (MRNA) reported total costs & expenses of $1.78B in Q1 2026.
How has Moderna's total costs & expenses changed year-over-year?
Moderna's total costs & expenses increased by 53.5% year-over-year, from $1.16B to $1.78B.
What is the long-term trend for Moderna's total costs & expenses?
Over 4 years (2021 to 2025), Moderna's total costs & expenses has grown at a -0.8% compound annual growth rate (CAGR), from $5.18B to $5.02B.